Volume 93 Issue 20 | pp. 32-34
Issue Date: May 18, 2015

Mass Spec Welcome In Clinical Labs

Use of mass spec for clinical diagnostics is increasing, but labs face uncertainty about FDA’s plans to regulate tests
Department: Science & Technology | Collection: Life Sciences
News Channels: Analytical SCENE, Biological SCENE
Keywords: mass spectrometry, clinical diagnostics, immunoassays, vitamin D, lab-developed tests, FDA

Every year, clinical labs perform more than 7 billion tests on blood, urine, and other samples from patients, according to the American Clinical Laboratory Association. Most of those tests involve an immunoassay, a diagnostic that uses antibodies to detect molecules of interest. But for a growing number of tests, mass spectrometry is the method of choice for analyzing samples. Labs use the technology for monitoring both therapeutic and frequently abused . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society